| Mr Curtis Brian Dubois, PT | |
|
2111 Sawyer Dr, Niagara Falls, NY 14304-2975 | |
| (716) 731-2195 | |
| (716) 731-4862 |
| Full Name | Mr Curtis Brian Dubois |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 2111 Sawyer Dr, Niagara Falls, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245223106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0060961 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Curtis Brian Dubois, PT 2111 Sawyer Dr, Niagara Falls, NY 14304-2975 Ph: (716) 731-2195 | Mr Curtis Brian Dubois, PT 2111 Sawyer Dr, Niagara Falls, NY 14304-2975 Ph: (716) 731-2195 |
News Archive
International clinical guidelines on the matter are hazy, with different practices followed in different countries. For a serious condition like osteoporosis, affecting millions, it is important to establish clear protocols.
Asthma is the most common chronic illness affecting Latino children in the United States, and secondhand smoke is a serious contributing factor. Now a new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine and Brown University suggests that clinically-based smoking cessation programs may not be enough to help Latino smokers with asthmatic children kick the habit.
Emergency Medical Services Corporation today announced that it is reviewing various strategic alternatives to enhance stockholder value.
With all of the media attention on young people being tormented by bullies and cyberbullies, parents may wonder what they can do to protect their children. The question they may want to ask instead is how can they prevent their child from becoming a bully.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
› Verified 3 days ago
Alexandra Kirstin Grant, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 924 Main Street, Niagara Falls, NY 14301 Phone: 716-282-2888 Fax: 716-285-1281 | |
Dr. Karla Rodriguez, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2600 Niagara Falls Blvd, Niagara Falls, NY 14304 Phone: 716-215-8000 | |
Mrs. Amy Lynn Murdock, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Colomba Dr Ste 5, Niagara Falls, NY 14305 Phone: 716-298-2249 Fax: 716-297-3302 | |
Miss Erin Luise Klettke, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 Colomba Dr Ste 5, Niagara Falls, NY 14305 Phone: 716-298-2249 | |
Ryan Alfred Joyce, PT,DPT,CSCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 924 Main St, Niagara Falls, NY 14301 Phone: 716-282-2888 Fax: 716-285-1281 | |
Access Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 2316 Pine Ave, Niagara Falls, NY 14301 Phone: 716-284-4474 Fax: 716-284-4484 | |
Janet M Osetkowski, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2316 Pine Ave, Niagara Falls, NY 14301 Phone: 716-284-4474 Fax: 716-284-4844 |